Join Merit Oncology for Breakfast & Harness the Power of RADAR | April 2023
Merit Medical Oncology
We're on a Mission to Ease the Burden Cancer Places on Patients and Their Loved Ones. #BreastSurgery #PatientCare
Disruptive Innovation: Harness the Power of RADAR
You are invited to attend the 24th Annual ASBrS Breakfast Event, Disruptive Innovation: Harness the Power of RADAR, hosted by Merit Medical.
SCOUT? Radar Localization exclusively spans the care continuum from time of biopsy placement to targeted axillary dissection to excellent surgical outcomes. Discover Key Opinion Leaders' state-of-the-art localization, biopsy and surgical management approaches that ease the burden on breast cancer patients while streamlining care and reducing costs. Learn about upcoming SCOUT product enhancements and the clinical and economic rationale for placing SCOUT at time of biopsy.
DATE: Friday, April 28, 2023
TIME: 6:15-7:45AM EST
LOCATON: Sheraton Boston Hospital – Republic Ballroom
Official Statement: Performance and Practice Guidelines for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer
Official Statement from The American Society of Breast Surgeons regarding the "Performance and Practice Guidelines for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer" states:
"Pre-treatment contrast-enhanced MRI is optional, but may aid in identifying tumor growth patterns that may influence the surgical approach and/or impact decisions regarding breast conserving surgery. Contrast-enhanced MRI is also the most accurate breast imaging study for determination of the extent of residual disease post-NST."
"Breast MRI may be performed to estimate the extent of residual locoregional disease. MRI is superior to clinical breast examination, mammography, and ultrasound for assessing the extent of residual breast disease after NST."
领英推荐
Excellent Visibility Under Imaging.
Choose Wisely. Choose SCOUT.
Place SCOUT at Anytime in the Care Continuum Under the Widest Array of Imaging Platforms on the Market
Clinically Insignificant MRI Artifact when Gauging Clinical Response
Published MRI Artifact Comparison of Wire-Free Technologies
?2023 Merit Medical Systems, Inc. All rights reserved.